(Q35732142)

9 August 2017

1 reference

title

Dietary prevention of allergic diseases in infants and small children. Part I: immunologic background and criteria for hypoallergenicity (English)

1 reference

9 August 2017

19

Hugh Sampson

1 reference

9 August 2017

25

Magnus Wickman

1 reference

9 August 2017

22

Ulrich Wahn

1 reference

9 August 2017

26

Robert S Zeiger

1 reference

9 August 2017

1

Antonella Muraro

1 reference

9 August 2017

Sten Dreborg

2

1 reference

9 August 2017

Susanne Halken

3

1 reference

9 August 2017

Arne Høst

4

1 reference

9 August 2017

Bodo Niggemann

5

1 reference

9 August 2017

Rob Aalberse

6

1 reference

9 August 2017

Syed H Arshad

7

1 reference

9 August 2017

Andrea von Berg Av

8

1 reference

9 August 2017

Kai- Hå kon Carlsen

9

1 reference

9 August 2017

Karel Duschén

10

1 reference

9 August 2017

Philippe Eigenmann

11

1 reference

9 August 2017

David Hill

12

1 reference

9 August 2017

Catherine Jones

13

1 reference

9 August 2017

Michael Mellon

14

1 reference

9 August 2017

Göran Oldeus

15

1 reference

9 August 2017

Arnold Oranje

16

1 reference

9 August 2017

Cristina Pascual

17

1 reference

9 August 2017

Susan Prescott

18

1 reference

9 August 2017

Magnus Svartengren

20

1 reference

9 August 2017

Yvan Vandenplas

21

1 reference

9 August 2017

Jill A Warner

23

1 reference

9 August 2017

John O Warner

24

1 reference

9 August 2017

language of work or name

1 reference

1 April 2004

1 reference

Pediatric Allergy & Immunology

9 August 2017

published in

1 reference

9 August 2017

volume

15

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

103-111

1 reference

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-3038.2003.00129.X

Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-3038.2003.00129.X

Reduced interferon gamma production by antigen-stimulated cord blood mononuclear cells is a risk factor of allergic disorders--6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-3038.2003.00129.X

Development of allergen-specific T-cell memory in atopic and normal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-3038.2003.00129.X

Effects of maternal allergen-specific IgG in cord blood on early postnatal development of allergen-specific T-cell immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-3038.2003.00129.X

In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-3038.2003.00129.X

A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-3038.2003.00129.X

Hypoallergenicity of an extensively hydrolyzed whey formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-3038.2003.00129.X

Cellular immune responses to ovalbumin and house dust mite in egg-allergic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-3038.2003.00129.X

10.1046/J.1399-3038.2003.00129.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference